Invention Grant
- Patent Title: Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
- Patent Title (中): 流感疫苗,包括颗粒状佐剂和免疫增强剂的组合
-
Application No.: US12092162Application Date: 2006-11-06
-
Publication No.: US08697087B2Publication Date: 2014-04-15
- Inventor: Rino Rappuoli , Derek O'Hagan , Giuseppe Del Giudice
- Applicant: Rino Rappuoli , Derek O'Hagan , Giuseppe Del Giudice
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Helen Lee; Otis Littlefield
- International Application: PCT/GB2006/004133 WO 20061106
- International Announcement: WO2007/052058 WO 20070510
- Main IPC: A61K39/39
- IPC: A61K39/39 ; C12N1/20

Abstract:
Influenza vaccines containing insoluble particulate adjuvants have been found to elicit an IgG response that is primarily a TH2 response (IgG1). This response can be shifted towards a TH1 response (IgG2a) by including immunopotentiators in the compositions. Thus the invention provides an immunogenic composition comprising: (i) an influenza virus antigen; (ii) an insoluble particulate adjuvant; and (iii) a immunopotentiator.
Public/Granted literature
- US20090304739A1 INFLUENZA VACCINES INCLUDING COMBINATIONS OF PARTICULATE ADJUVANTS AND IMMUNOPOTENTIATORS Public/Granted day:2009-12-10
Information query